Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Many patients receiving dialysis in the USA share the socioeconomic characteristics of underserved communities, and undergo routine monthly laboratory testing, facilitating a practical, unbiased, and repeatable assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet

Title: Lancet (London, England)

Publisher: Elsevier BV

ISSN (Electronic): 1474-547X

ISSN (Print): 0140-6736

Publication date (Electronic): Oct 24 2020

Volume: 396

Issue: 10259

Affiliations

[1 ] Division of Nephrology, Stanford University, Palo Alto, CA, USA. Electronic address: sanand2@stanford.edu.

[2 ] Division of Nephrology, Stanford University, Palo Alto, CA, USA.

[3 ] Ascend Clinical Laboratory, Redwood City, CA, USA.

[4 ] Division of Infectious Diseases & Geographic Medicine, Stanford University, Palo Alto, CA, USA; Department of Medicine, and Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA.

[5 ] Division of Nephrology, Stanford University, Palo Alto, CA, USA; Department of Medicine, and Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA.

Article

Publisher Item ID: S0140-6736(20)32009-2

DOI: 10.1016/S0140-6736(20)32009-2

PMC ID: 7518804

PubMed ID: 32987007

SO-VID: 58097451-66b2-4a64-8c18-45a9aba27393

History

Data availability:

Comments

Comment on this article

scite_

Cited by 10

See all cited by